Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$42.05 - $47.77 $163,784 - $186,064
-3,895 Reduced 29.69%
9,226 $402,000
Q1 2022

May 13, 2022

SELL
$40.23 - $47.74 $105,281 - $124,935
-2,617 Reduced 16.63%
13,121 $572,000
Q4 2021

Feb 11, 2022

SELL
$38.88 - $45.31 $423,675 - $493,743
-10,897 Reduced 40.91%
15,738 $694,000
Q3 2021

Nov 12, 2021

BUY
$38.79 - $43.16 $187,084 - $208,160
4,823 Added 22.11%
26,635 $1.02 Million
Q2 2021

Aug 13, 2021

SELL
$36.52 - $41.46 $4,528 - $5,141
-124 Reduced 0.57%
21,812 $869,000
Q1 2021

May 14, 2021

SELL
$34.27 - $40.01 $102,775 - $119,989
-2,999 Reduced 12.03%
21,936 $783,000
Q4 2020

Feb 05, 2021

SELL
$34.07 - $39.94 $388,466 - $455,395
-11,402 Reduced 31.38%
24,935 $918,000
Q3 2020

Nov 06, 2020

SELL
$38.11 - $42.99 $128,926 - $145,435
-3,383 Reduced 8.52%
36,337 $1.37 Million
Q2 2020

Aug 13, 2020

BUY
$37.87 - $43.58 $175,224 - $201,644
4,627 Added 13.18%
39,720 $1.62 Million
Q1 2020

May 14, 2020

BUY
$32.47 - $48.83 $1,720 - $2,587
53 Added 0.15%
35,093 $1.33 Million
Q4 2019

Feb 14, 2020

SELL
$42.0 - $48.25 $310,800 - $357,050
-7,400 Reduced 17.44%
35,040 $1.65 Million
Q3 2019

Nov 01, 2019

BUY
$40.46 - $43.52 $68,782 - $73,984
1,700 Added 4.17%
42,440 $1.81 Million
Q2 2019

Aug 02, 2019

SELL
$39.4 - $42.7 $174,936 - $189,588
-4,440 Reduced 9.83%
40,740 $1.63 Million
Q1 2019

May 02, 2019

BUY
$38.57 - $42.69 $1.74 Million - $1.93 Million
45,180 New
45,180 $1.89 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.4B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.